Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Looking for help w/numbers for burn rate, cash on hand, et.

<< Previous

Bullboard Posts

Next >>

Post by BuenaSuertaAtodon Apr 29, 2021 1:46pm

355 Views

Post# 33094455

Looking for help w/numbers for burn rate, cash on hand, et.

I've read here that $390K/mo was burn rate for 2020. $390 x 12mo = $4,680K for the year.

I've also read here that $7,800k cash on hand remains at YE 2020. $7,800K + $4,680K = $11,480K

In Jan 2020 units were issued that raised total gross funds of at least $17,250,000. Net would be quite a bit less than that. Just the same, if $4,680 was what they burned through in 2020 there ought to be more cash left over from that PP than $7,800K shouldn't there?

Where have my numbers gone wrong?

<< Previous

Bullboard Posts

Next >>

Opawica seeks drill permits for Bazooka Gold Targets in Abitibi